Company Information
- Type:
- Company
- Country:
- United Kingdom
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Active
- Participant Since
- 12 December 2007
- Next Communication on Progress (COP) due on:
- 31 July 2024
Financial Information
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 17-Nov-2023 | 2023 Communication on Progress | Submitted |
| 13-May-2022 | Hikma Sustainability Report 2021 - Acting Responsibly | Active |
| 30-Jun-2021 | 2020 Sustainability Report and Communication on Progress | Active |
| 13-May-2021 | Grace Letter | Not applicable |
| 03-Dec-2020 | Reporting Cycle Adjustment | Not applicable |
| 04-Dec-2019 | Hikma Pharmaceuticals Communication on Progress 2018 | Active |
| 05-Dec-2018 | Hikma Communication on Progress 2017 | Active |
| 05-Dec-2017 | Hikma Communication on Progress 2016 | Active |
| 07-Dec-2016 | Communication on Progress 2015 | Active |
| 08-Dec-2015 | Hikma Communication on Progress 2014 | Active |
| 09-Dec-2014 | Hikma Communication on Progress 2013 | Active |
| 11-Dec-2013 | Hikma Communication on Progress 2012 | Active |
| 13-Dec-2012 | Hikma Communication on Progress 2011 | Active |
| 14-Dec-2011 | Hikma Communication on Progress 2010 | Active |
| 14-Dec-2010 | 2009 Communication on Progress | Not applicable |
| 13-Dec-2009 | Global Compact End of Year Communication on Progress (COP) 2008 | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.